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Lactobacillus reuteri was demonstrated to possess several 
positive features supporting its employment as a probiotic. 
First it produces several antimicrobial compounds, useful to 
treat or prevent infectious diseases, such as: i) reuterin, bio-
synthesized during anaerobic catabolism of glycerol and 
active against a broad range of pathogenic microorganisms 
[1,2] ii) reutericin, a bacteriocin of 2,7 kDa displaying lytic 
activity [3] iii) reutericyclin, a highly hydrophobic tetramic 
acid derivative, with a molecular mass of 349 Da exhibiting a 
broad inhibitory spectrum [4]. Additional antimicrobial 
features have recently been described in this species like the 
ability to neutralize toxins produced by fungi [5], to modu-
late expression of toxins in different bacterial species [6] and 
to co-aggregate with toxinogenic Staphylococcus aureus [7]. 
Furthermore L. reuteri displays anti-inflammatory proper-
ties linked to a factor secreted by the biofilm-forming cells 
[8]. All these features highlight a strong attitude of this bac-
terial species not only to counteract infections but also to 
attenuate their severity. 
More recently the use of a Lactobacillus reuteri Lb2 BM 
DSM 16143, the strain investigated in this study, has been 
suggested as nutraceutical supplement, for oxidative stress 
protection in the human host [9,10]. 
Besides the most common pre-requisites to define a strain 
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Abstract 
1. Introduction 
The adhesion ability of the probiotic Lactobacillus reuteri Lb2 BM DSM 16143 was tested to both enterocyte-like Caco-2 cells and to extracel-
lular matrix proteins (laminin, fibronectin and collagen I and IV). The adhesiveness was lost after an alkaline treatment known to release 
moonlighting  proteins from lactobacillar cell surface. To characterize the putative adhesive molecules, a 2-DE experiment in the pI range 4-7 
was performed on the extracellular proteins. The expression of several moonlighting proteins involved in adhesion (i.e. GAPDH, EF-Tu, 
phosphoglycerate kinase) was demonstrated. Some of the identified adhesins were able to bind plasminogen (Plg), but did not convert it into 
plasmin (Plm), in absence of exogenous activators. This indicates that the moonlighting proteome of L. reuteri Lb2 BM DSM 16143 can con-
tribute to adhesion processes.  
Keywords: extracellular matrix protein; bacterial adhesion; moonlighting proteins; 2DE; plasminogen binding. 
Mangiapane et al., 2013 | Journal of Integrated Omics 
145-156: 146 
as a probiotic (pH, gastric enzymes and bile salt resistance) 
additional important features are adhesion and metabolic/
biochemical safety (GRAS status). 
Adhesion of probiotics to the mucosal surface is critical for 
exerting beneficial effects to the host organism [11]. It is first 
driven by weak forces, like Coulomb and Van der Waals 
attractions, and mediated by several bacterial binding-
effectors such as polysaccharides [12], teichoic and lipo-
teichoic acids [13] followed by the specific production of 
proteins named adhesins [14]. Several studies have demon-
strated that in some Lactobacillus species, glycolytic enzymes 
(such as GAPDH, phosphoglycerate kinase and mutase), 
protein folding and stress responses-involved proteins 
(GroEL and DnaK), as well as transcription and translation 
proteins (elongation factor Tu, Ts and trigger factor) can 
exert an adhesive function when they are secreted and sur-
face-exposed [15,16,17]. Some of these adhesins also play a 
role in plasminogen (Plg) binding. In pathogenic bacteria 
(Staphylococcus aureus and Streptococcus pneumoniae) this 
constitutes a problem since they also biosynthesize enzymes 
(staphylokinases and streptokinases) able to convert Plg to 
plasmin (Plm), its proteolytic active form, that can damage 
tissues opening the way for blood colonization and body 
invasion. To date, although Plg binding capability has also 
been described for probiotic bacteria [18], their intrinsic 
potential (kinases) for Plg activation to Plm has never been 
demonstrated.  
The adhesins cited above are defined “moonlighting pro-
teins”, i.e. proteins displaying different functions according to 
their subcellular localization [19]. They lack any anchoring 
motif or surface retention domain [20] and can be easily 
released from bacteria, either due to the normal cell-wall 
turnover [21] or to disturbances in cell wall permeability 
resulting from pH-stress [18] or exposure to host antimicro-
bial peptides [22]. In LAB no classical signal peptide respon-
sible for moonlighting protein export has been identified so 
far. Nevertheless, it has been demonstrated in Bacillus sub-
tilis that these proteins contain one additional alpha-helix 
responsible for their secretion [23]. 
A proteomic approach applied on the cell wall and extra-
cellular proteomes can confirm the external location of such 
proteins. This information could not be obtained by a classi-
cal genome-transcriptome-based characterization since these 
adhesins, belonging to the main metabolic pathways, are 
constitutively expressed.  
In the present study the adhesive ability of L. reuteri Lb2 
BM DSM 16143 has been tested both on Caco-2 cells and 
extracellular matrix (ECM) proteins. These experiments 
were combined in a wide integrated approach, with classic 
2DE proteomic experiments on the extracellular proteins in 
order to verify the presence of moonlighting proteins in-
volved in adhesion. In parallel, other experiments were per-
formed to evaluate if the detachment of such proteins from 
the cell wall was pH-dependent and if it could result in a 
decrease in the adhesion ability of the strain. Finally to en-
sure safety we investigated the intrinsic ability of the strain 
to activate proteolytic cascades.  
2. Material and Methods 
2.1 Bacterial strain and culture conditions 
Lactobacillus reuteri Lb2 BM DSM 16143 was isolated from 
a human faecal sample and it belongs to the collection of 
BioMan life science S.r.l. It was maintained in a modified 
MRS (de Man, Rogosa and Sharpe) medium (10 g/L Tryp-
tone enzymatic digest from casein, 8 g/L Peptone from soy-
bean, 10 g/L Yeast extract, 10 g/L Sucrose, 1 ml/L Tween80, 
2 g/L Potassium phosphate dibasic, 5 g/L Sodium acetate, 2 
g/L Ammonium citrate tribasic anhydrous, 0.2 g/L Magnesi-
um sulfate, 0.05 g/L Manganese sulfate) at - 24°C in 0.5 mL 
aliquots with 0.5 mL of 40% glycerol. 
The cultures were grown in closed screw cap bottles, at 37 °
C, without shaking. The pH of the medium was adjusted at 
6.4 before the inoculum. The bacterial growth was moni-
tored by 600 nm optical density (OD600) measurement. 
For all the cultures three biological replicates were per-
formed. 
2.2 Adhesion assay on Caco-2 cells 
The adhesion ability of Lactobacillus reuteri Lb2 BM DSM 
16143 to human intestinal cells was evaluated using entero-
cyte-like Caco-2 cells (ATCC HTB37). The cells were grown 
in six-well plates in a monolayer with DMEM (Dulbecco’s 
modified Eagle’s medium, Gibco TM life technologies) and 
incubated for 15 days at 37°C, in a 10% CO2 atmosphere. The 
culture medium was replaced every 48 hours and the mono-
layers of Caco-2 cells were used at post-confluence when 
they were fully differentiated. Intestinal cells were used be-
tween passages 25 and 35. Before starting the adhesion trial, 
Caco-2 cells were washed twice with phosphate-buffered 
saline (PBS, pH 7.4) and then a bacterial pellet, harvested 
during the exponential growth phase and resuspended in 1 
mL of PBS was added onto Caco-2 cells. The cells were incu-
bated for 1 h at 37°C in 10% CO2. Then the monolayers were 
washed five times with sterile PBS to remove all the non-
adhered bacterial cells. The washed monolayers were treated 
with 1 mL of 0.05% Triton X-100 PBS solution for 10 min to 
detach the Caco-2 cells with the adhered bacteria from the 
plate. The recovered solution was immediately centrifuged 
(4000 x g, 15 min, 4°C) to pellet cells and bacteria in order to 
avoid potential bacterial lysis due to Triton X-100 action. 
The number of colony forming units/mL (CFU/mL) was 
determined by plating serial 10-fold dilutions onto MRS agar 
before and after adhesion and incubated for 48 h at 37°C. 
The adhesion capacity was described as the percentage of 
bacteria adhered to Caco-2 cells relative to the total number 
of bacteria added. For all the cultures three technical repli-
cates and two biological replicates were performed. The same 
experiment was performed on the positive control Lactoba-
cillus rhamnosus GG which is known for its adhesive proper-
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ties [24].  
2.3 Adhesion assay on extracellular matrix proteins 
Adhesion ability of L. reuteri LB2 BM DSM 16143 to ex-
tracellular matrix proteins and pH-dependent variations 
were tested at pH 4 and pH 8. After growth in modified MRS 
broth bacteria were collected (4000 x g, 10 min), washed 
twice with either 50 mM Tris-HCl buffer at pH 4 or pH 8 
and finally resuspended at a concentration of 1 x 109 bacte-
ria/mL in the same Tris-HCl buffer. Lactobacillus adherence 
to surface coated laminin (Sigma), fibronectin (Collaborative 
Biomedical Products), collagen types I and IV (Sigma) were 
performed as already described using 2.5 pmol surface con-
centration [25,26]. Bovine Serum Albumin (BSA) (Sigma), a 
control protein, was coated on glass surface from a solution 
of 25 μg/mL. The bacteria were incubated with coated target 
proteins on diagnostic slides for 2 h at room temperature. 
After incubation the slides were washed with 50 mM Tris-
HCl buffer either at pH 4 or pH 8. The adherent bacteria 
were stained with methylene blue and slides were analyzed 
with light microscopy using NIH image software (Research 
Services Branch, National Institute of Health) [27]. The 
number of bacteria in 20 microscopic fields of 1.6 x 104 μm2 
were counted.  
2.4 SDS-PAGE of surface associated proteins 
L. reuteri Lb2 BM DSM 16143 was grown in modified MRS 
medium until the exponential growth phase. Bacteria were 
centrifuged at 4000 x g for 20 minutes and supernatant was 
removed. Pellets were resuspended in 200 mL of 50 mM Tris
-HCl pH 8, and incubated one hour at 37°C in shaking mode 
(GallenKamp Orbital Incubator). After a centrifugation at 
4000 x g for 20 minutes (4°C, Thermo Scientific SL 16R), su-
pernatants were filtered with Stericup filters (Millipore) and 
Trichloroacetic Acid 16% w/v was added to promote pro-
teins precipitation under shaking over night at 4°C. The ob-
tained suspensions were then ultracentrifuged (35000 x g, 90 
min, 4°C). Pellets were dried, pulverized and resuspended in 
50 mM Tris-HCl pH 7.3. 1 mL aliquots of the obtained sam-
ple were subjected to phenol extraction as described before 
[28]. Briefly, 1 mL phenol was added and the mixtures were 
incubated for 10 min at 70°C and for 5 min at 0°C and cen-
trifuged (7000 x g, 10 min, room temperature). The upper 
phase was discarded and 1 mL of MilliQ water was added to 
the lower phase, which was then incubated for 10 min at 70°
C and for 5 min at 0°C and centrifuged (7000 x g, 10 min, 
room temperature) again. The upper phase was discarded 
and 1 mL of ice cold acetone was added to the lower phase 
before incubating over night at -20°C. Precipitated proteins 
were recovered by centrifuging (15000 x g, 20 min, 4°C) and 
washed with ice cold acetone (15000 x g, 20 min, 4°C). Pel-
lets were pulverized, resuspended in Laemmli loading dye 
[29] and loaded on a 9.5% resolving gel and run at 120V for 
1 hour.  
2.5 Protein identification of SDS-PAGE bands 
Bands were excised from the dried gels and rehydrated 
with MilliQ water. They were washed twice with 50% v/v 
ACN in a 25 mM NH4CO3 and once in 100% v/v ACN and 
vacuum-dried. The proteins were in-gel digested with se-
quencing-grade, modified porcine trypsin (Promega, Madi-
son, WI, USA) and added to a MALDI target plate as de-
scribed by Hewitson et al. [30]. Positive-ion MALDI mass 
spectra were obtained using an Applied Biosystems 4700 
Proteomics Analyzer (Applied Biosystems, Foster City, CA, 
USA) in reflectron mode. MS spectra were acquired over a 
mass range of m/z 800–4000 and monoisotopic masses were 
obtained from centroid of raw, unsmoothed data. Finally, 
the mass spectra were internally calibrated using the tryptic 
autoproteolysis products at m/z 842.509 and 2211.104. CID-
MS/MS was performed on the 20 strongest peaks with an S/
N greater than 40. A source 1 collision energy of 1 kV was 
used for CID-MS/MS, with air as the collision gas. The pre-
cursor mass window was set to a relative resolution of 50, 
and the metastable suppressor was enabled. Default calibra-
tion was used for the MS/MS spectra, which were baseline-
subtracted (peak width 50) and smoothed (Savitsky-Golay 
with three points across a peak and a polynomial order of 4); 
the peak detection used a minimum S/N of 5, a local noise 
window of 50 m/z, and a minimum peak width of 2.9 bins. S/
N 20 and 30 filters were used to generate peak lists from the 
MS and MS/MS spectra, respectively. The mass spectral data 
from the protein spots were submitted to a database search 
using a locally running copy of the MASCOT programme 
(Matrix Science, version 2.1). Batch-acquired MS/MS data 
were submitted to an MS/MS ion search through the Ap-
plied Biosystem GPS explorer software interface (version 
3.6) with MASCOT. The search parameters allowed a maxi-
mum of one missed cleavage, the carbamidomethylation of 
cysteine, the possible oxidation of methionine, peptide toler-
ance of 100 ppm and an MS/MS tolerance of 0.1 Da. The 
spectra were searched against a recent version of the NCBI 
non-redundant protein database. The significance threshold 
was set at p<0.05, and identification required that each pro-
tein contain at least one peptide with an expect e-value 
<0.05. 
2.6 Preparation of extracellular protein extracts 
L. reuteri Lb2 BM DSM 16143 was grown in modified MRS 
medium in biological triplicate. The biomass of middle expo-
nential phase was separated by centrifugation (4000 x g, 20 
min, 4°C) and culture supernatants were filtered in stericup 
0.22 μm filters (Millipore). The supernatant was treated as 
already described in the paragraph “SDS-PAGE of surface 
associated proteins”. The obtained pellets were pulverized, 
resuspended in rehydration solution (6.5 M urea, 2.2 M thio-
urea, 4% w/v CHAPS, 5 mM Tris-HCl, pH 8.8, 0.5% IPG 
buffer (GE-Healthcare), 100 mM DTT) and stored at -20°C. 
Protein concentration was determined by Bradford assay 
(Bio Rad). 
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2.7 2-DE 
Isoelectrofocusing (IEF) was performed as previously de-
scribed [31]. Two hundred and seventy-five μg of proteins 
were separated in 13 cm IPG strips (GE Healthcare) with a 
linear gradient ranging from 4 to 7 using IPGphor (GE 
Healthcare) at 20°C, with 83000 Vh, after 10 h rehydration. 
After IEF, the strips were incubated at room temperature in 
6 M urea, 30% v/v glycerol, 2% w/v SDS, 50 mM Tris-HCl, 
pH 8.6, enriched at first with 2% w/v DTT for 15 min and 
afterwards with 4.5% w/v iodoacetamide for 15 min. They 
were then sealed at the top of the 1.0 mm vertical second 
dimension gels. For each sample, SDS-PAGE was carried out 
on 11.5% T and 3.3% C acrylamide (Biorad Acrylamide) 
homogeneous gels. The running buffer was 25 mM Tris, 192 
mM glycine, 0.1% SDS. The running conditions were 11°C, 
600V constant voltage, 20 mA/gel, 60W for 15 min and 11°
C, 600 V constant voltage, 40 mA/gel, 80W for about 2.5 h. 
The molecular weight markers were from the Low Mr Elec-
trophoresis Calibration Kit (GE-Healthcare). The gels were 
automatically stained using Processor Plus (Amersham Bio-
sciences) with freshly prepared Neuhoff stain (Colloidal 
Coomassie Blue) [32] and, after image acquisition, they were 
dried in a GD 2000 Vacuum Gel Drier System (GE 
Healthcare). 
2.8 Image analysis and statistical analysis 
2-DE gels were digitized with Personal Densitometer SI 
(Amersham Biosciences). Image analysis and spot detection 
were performed with Progenesis PG200 software (Non Line-
ar Dynamics). Spot detection was automatically performed 
by using the algorithm named “2005 detection”. After the 
establishment of some user seeds, matching was automati-
cally performed and manually verified. Two analytical repli-
cates of 2-DE maps of extracellular proteins obtained from 
each of the three biological replicates were performed. Only 
spots present in at least five out of six replicates were identi-
fied. 
2.9 Protein identification of 2DE gels 
Enzymatic digestion was carried out with 200 ng of trypsin 
in 50 μL of 10 mM NH4CO3 buffer, pH 7.8. Gel pieces were 
incubated at 37°C overnight. Peptides were then extracted 
by washing the gel particles with 10 mM NH4CO3 and 1% 
formic acid in 50% ACN at room temperature. The resulting 
peptide mixtures were filtrated using 0.22 PVDF filter from 
Millipore. The peptide mixtures were analysed by nanoLC-
chip MS/MS, using a CHIP MS 6520 QTOF equipped with a 
capillary 1200 HPLC system and a chip cube (Agilent Tech-
nologies). After loading, the peptide mixture (8 μL in 0.1% 
formic acid) was first concentrated and washed at 4 μL/min 
in 40 nL enrichment column (Agilent Technologies chip), 
with 0.1% formic acid as eluent. The sample was then frac-
tionated on a C18 reverse-phase capillary column (75 μm x 
43 mm in the Agilent Technologies chip) at flow rate of 400 
nL/min with a linear gradient of eluent B (0.1% formic acid 
in 95% ACN) in A (0.1% formic acid in 2% ACN) from 7 to 
60 % in 50 min. Doubly and triply charged peptides were 
selected and analyzed using data-dependent acquisition of 
one MS scan (mass range from 300 to 2,000 m/z) followed by 
MS/MS scans of the three most abundant ions in each MS 
scan. Collision energy (CE) applied during peptide fragmen-
tation is calculated by the sequent empirical equations: CE= 
4V/100Da -2,4V. Raw data from nanoLC–MS/MS were ana-
lyzed and converted in common spectral file formats 
(.mgf  mascot generic file), using Qualitative Analysis soft-
ware (Agilent MassHunter Workstation Software, version 
B.02.00). MASCOT software (www.matrixscience.co) ver-
sion: 2.4.0 was used for the protein identification against 
NCBInr database (NCBInr_20120920.fasta; 21582400 se-
quences; 7401135489 residues), with the taxonomy re-
striction to Other Firmicutes (2926062 sequences). The 
MASCOT search parameters were: “trypsin” as enzyme al-
lowing up to 3 missed cleavages, carbamidomethyl on cyste-
ine residues as fixed modification, oxidation of methionine 
and formation of pyroGlu N-term on glutamine were select-
ed  as variable modifications, 10 ppm MS/MS tolerance and 
0.6 Da peptide tolerance. By data analysis, threshold provid-
ed to evaluate quality of matches for MS/MS data was found 
to be 41.  
2.10 Plasminogen activation assay 
tPA-specific plasminogen activation assay in the presence 
of L. reuteri Lb2 BM DSM 16143 cells or its surface associat-
ed proteins were measured as described by Lähteenmäki et 
al. [33]. Overnight grown bacteria were divided into two ali-
quots: bacteria of the first aliquot were collected and resus-
pended in PBS (pH 7.1) at a concentration of 1 x 1010 bacte-
ria/mL. Bacteria of the second aliquot were incubated in 50 
mM Tris-HCl pH 8 for 1 h at 37 °C to release surface associ-
ated proteins; after pelleting the bacteria, supernatant was 
filtrated through a 0.2 μm filter to remove the bacterial cells. 
Bacteria (20 μl) or surface associated proteins (50 μl) were 
incubated with 4 μg of human Glu-Plg (American Diagnosti-
ca), 2 ng of tPA (Biopool) and 0.45 mM chromogenic sub-
strate of plasmin S-2251 (Kabivitrum) in a total volume of 
200 μl. The plasmin formation was verified by evaluation of 
the increase in plasmin activity assessed by measuring the 
Optical Density at 405 nm every 30 minutes for a 4-hour 
long period. Three biological replicates were tested and for 
every culture two technical replicates were performed. Mean 
values were subtracted to the values measured at time 0.  
3. Results and Discussion 
The ability of a probiotic to adhere to the epithelial mucosa 
is crucial for intestinal colonization [34]. It is the first step 
required for competitive exclusion of entero-pathogens and 
for intestinal micro-ecology modification. Microbial coloni-
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zation of gut epithelium requires that bacteria first bind to 
extracellular secreted constituents, and then adhere to cell-
surface membranes or to extracellular matrix (ECM) pro-
teins [35]. Therefore the adhesiveness of L. reuteri Lb2 BM 
DSM 16143 was tested in two biological models: the entero-
cyte-like Caco-2  cells and the  purified proteins of the ECM. 
3.1 L. reuteri Lb2 BM DSM 16143 adhesion on enterocyte-like 
Caco-2 cells  
An in vitro binding assay was performed to evaluate the 
adhesion capacity of  L. reuteri Lb2 BM DSM 16143 on en-
terocyte-like Caco-2 cells, a model for the intestinal epitheli-
um that displays a good correlation to in vivo conditions 
[36]. The adhesion capacity (AC) is described as the percent-
age of bacteria adhered to Caco-2 cells relative to the total 
number of bacteria added. The obtained value for the strain 
in study is equal to 0,82 ± 0,17 % in comparison to the value 
3,2 ± 0,41 % obtained for the positive control Lactobacillus 
rhamnosus GG. Therefore L. reuteri Lb2 BM proved to be a 
moderate adhesive strain and these results prompted us to 
go more in depth in the evaluation of its adhesion capability.  
3.2 L. reuteri Lb2 BM DSM 16143 adhesion assays on ECM 
proteins  
The first targets for bacteria attachment are the main ex-
tracellular matrix proteins: laminin, fibronectin and colla-
gens I and IV. Therefore, the adhesiveness of L. reuteri Lb2 
BM DSM 16143 was tested using the purified matrix pro-
teins. The adhesive process is mainly mediated by surface-
associated proteins expressed by microorganisms on their 
cell wall. In the literature this association has been proposed 
to be pH-dependent: surface proteins are positively charged 
at acidic pH values and therefore remain associated with the 
bacterial cell-wall by means of electrostatic interactions. 
Conversely moonlighting proteins of L. crispatus are re-
leased from cell surface in neutral or cationic buffers, which 
also reduces bacterial adhesiveness to ECM proteins [18]. 
For this reason the experiment was performed both at pH 4 
and 8. As shown in Figure 1A, at pH 4 the strain can effi-
ciently adhere to ECM proteins. Some differences in adhe-
siveness towards the four tested proteins can be observed: 
adhesion was stronger to collagen I, collagen IV and laminin 
than to fibronectin. As expected, a strong reduction of L. 
reuteri ability to adhere to ECM proteins was detected at pH 8 
(Figure 1B), confirming two hypotheses: 1. the adhesion is 
mediated by the proteins associated to the cell wall; 2. this 
association is pH-dependent. 
3.3 SDS-PAGE of L. reuteri Lb2 BM DSM 16143 surface-
associated proteins after detachment by alkaline treatment  
In order to further analyze the proteins released at high 
pH and involved in the adhesion process, bacteria were sub-
jected to an alkaline treatment (1 hour, pH 8) to induce the 
release of surface-associated proteins. After SDS-PAGE and 
MALDI TOF-TOF analysis, fourteen different proteins were 
identified (Table 1). Among these, ten are reported to be 
surface associated in different bacterial species; furthermore 
ornithine carbamoyltransferase, elongation factor Tu, puta-
tive elongation factor Tu and phosphopyruvate hydratase (α-
enolase) are directly involved in the adhesion process. Orni-
thine carbamoyltransferase is an arginine deiminase (ADI) 
pathway enzyme that was previously found on the surface of 
the opportunistic Staphylococcus epidermidis [37] and the 
pathogenic Clostridium perfrigens [38], where it acts as a 
fibronectin-binding adhesin. Elongation factor Tu (EF-Tu), 
a guanosine nucleotide-binding protein involved in protein 
synthesis, is responsible for adhesion when surface-exposed. 
Figure 1. Extracellular matrix adhesion assay. Adhesion ability (reported as number of cells recovered after incubation with coated 
slides for 2 hours) of L. reuteri Lb2 BM DSM 16143 on ECM (extracellular matrix) proteins at pH 4 (A) and pH 8 (B). Values are reported as 
mean ± SEM. 
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Both the cell wall/extracellular localization and the involve-
ment in the adhesion process of EF-Tu are well documented 
[39]: in Mycoplasma pneumoniae EF-Tu binds to fibron-
ectin [40], and in Lactobacillus johnsonii it is able to bind 
mucin and thus intestinal epithelial cells, also displaying 
immune-modulatory properties [13]. Also α-enolase has 
widely been reported to be surface located in both commen-
sal and pathogenic bacteria: in L. plantarum LM3 it is re-
sponsible for specifically binding human fibronectin [41], 
while in streptococci it mediates laminin binding [42]. Both 
EF-Tu and α-enolase, together with phosphoglycerate mu-
tase, were also proved to be involved in plasminogen (Plg) 
binding: EF-Tu binds Plg in Mycobacterium tuberculosis 
[43] while in commensal bacteria, such as L. crispatus ST1 
Table 1. MALDI-TOF TOF identifications of weakly bound surface-associated proteins detached after alkaline (pH 8) treatment derived 
from SDS-PAGE bands. Bands 4, 6, 7 and 8 contained more than one protein, as demonstrated by the MS identification. 
Bands  Score  Molecular weight  Identified protein  NCBI nr ID  Identified peptides 
1 407  49920  Phosphopyruvate hydratase gi|18415303 
LGANAILAVSLAAAR 
GIHSFYNLSQQAR 
GNPTVEAEVYTEAGGVGR 
GIVPSGASTGEHEAVELR 
VDFQEFMIMPVGAPTVR 
2 59  46790  NLP/P60 protein gi|148544580  QSQWGDWYLFGNDGR 
3  842  43405  Elongation factor Tu  gi|148543883 
GISHDQIQR 
TLDLGEAGDNVGVLLR 
HYAHIDAPGHADYVK 
TKPHVNIGTIGHVDHGK 
GITINTAHVEYETEKR 
DLLSEYDFPGDDVPVVR 
TDLVDDDELVDLVEMEVR 
4 
226  37650  Ornithine carbamoyltransferase  gi|148543661 
SFLTLADFNTR 
VLGGMFDGIEYR 
EMEVTDEVFESEHSVVFR 
225  36615  Alcohol dehydrogenase gi|158544709  TVLDGIIVAGSLVGTR 
VGGVHAAVVTAVSASAFDQAVDSLRPDGK 
95  36284  Mannitol dehydrogenase gi|45268465 EEIPADAYDIVVEAVGLPATQEQALAAAAR 
5  70  31999  Elongation factor Ts  gi|148543917  DVAMHVAAINPEFMTR 
6 
148  29115  30S ribosomal protein S2  gi|14853916  FLGGIEDMPR 
216  28078  Putative elongation factor Tu  gi|22266054  TLDLGEAGDNVGVLLR 
7 
73  26162  Phosphoglyceromutase  gi|148543385  YGDEQVHIWR 
115  25849  Dehydratase, medium subunit  gi|148544952 IHYQAISAIMHIR 
57  24681  30S ribosomal protein S3  gi|148544690  IESYSDGTVPLHTLR 
8 
57  23947  Propanediol utilization protein  gi|148544946  SENFTLGIDAPIR 
156  22929  30S ribosomal protein S4  gi|148543735  QFSNLFVR 
EGTHGANFMALLER 
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and Bifidobacterium lactis BI07, this function is mediated by 
α-enolase [18] and phosphoglycerate mutase [44] respective-
ly. 
3.4 L. reuteri Lb2 BM DSM 16143 2DE extracellular proteome  
Adhesive proteins are mainly surface-located, but, as 
demonstrated in the previous paragraphs and in the litera-
ture, both pH [18] and physiological cell-wall turnover dur-
ing the logarithmic growth phase [20,21], can give rise to a 
dynamic exchange of proteins between bacterial surface and 
extracellular space. The analysis of the extracellular proteo-
me of a probiotic may shed light on its adhesion mecha-
nisms and also confirm the safety of the strain in the tested 
conditions.  
Figure 2 shows the extracellular proteome of L. reuteri Lb2 
BM DSM 16143 in the 4-7 pI range. The 59 detected spots 
were all identified by nanoLC-chip MS/MS (Table 2, Table 
S1).  
Considering pI isoforms, 21 proteins were identified. It is 
possible to hypothesize that spots 1, 2 and 15 are pI isoforms 
derived from post translational modifications, i.e. phosphor-
ylations.  
It is interesting to underline that seven of these proteins 
(phosphopyruvate hydratase, Nlp/P60 protein, elongation 
factor Tu, elongation factor Ts, alcohol dehydrogenase, 
mannitol dehydrogenase, phosphoglycerate mutase) were 
also identified as surface-proteins detached by the treatment 
at pH 8 described in the previous paragraph. This observa-
tion is a further evidence of the dynamic protein exchange 
between extracellular space and cell-wall.  
Identified proteins were divided into three main functional 
families and listed in Table 2: i) cell wall processing enzymes; 
ii) adhesion-involved proteins; iii) other proteins. 
The first functional family is constituted by extracellular 
cell-wall processing enzymes. Bacterial cell wall is a very dy-
namic structure, especially during logarithmic growth and 
cell division [45]: all the proteins and protein domains de-
tected are involved in the cell-wall re-arrangement and in the 
control of the cell shape during division. This finding is in 
agreement with the recovery of the bacterial cells during the 
middle exponential growth phase.  
Mannosyl-glycoprotein endo-beta-N-acetylglucosamidase 
(spot 1) is a widespread enzyme in bacteria and catalyzes the 
hydrolysis of the glycosidic bond between N-acetyl-beta-D-
glucosamine residues and the adjacent monosaccharides in 
peptidoglycan [46]. Nlp/P60 (spot 3) is an endopeptidase 
family with various roles in the dynamics of the bacterial cell 
wall such as the control of cell morphology and cell separa-
tion process [47].  Apf1-like protein (spot 6),  is similar to 
Apf1 that was originally identified as one of the most abun-
dant proteins in the supernatant of L. gasseri 4B2 [48]. It is 
directly related to the bacterial cell shape: an over-
production produces twisted cells, while a down-regulation 
causes no visible cell separation sites giving to the cells an 
elongated shape [49]. The peptidoglycan-binding LysM (spot 
2, 4), is a repetitive domain consisting of 40 amino acids 
present in several peptidoglycan-binding enzymes [50]. It 
allows the non-covalent attachment of the majority of the 
extracellular proteins expressed by gram-positive bacteria to 
the cell-wall. Generally LysM domain is never present in 
Apf1 proteins. Bath and coworkers [51], nevertheless, 
demonstrated by bioinformatic analyses, that a LysM do-
main is present in L. reuteri ATCC 55730 Apf1-like protein. 
Interestingly in the same paper [51] it has been reported that 
the unknown extracellular protein lr1267 (spot 5), found 
also in this investigation, is an Apf-like protein.  
It has to be taken into account that some bacterial cell-wall 
lysis enzymes are not only involved in autolysis and cell-wall 
rearrangement, but also in bacterial interspecies interactions, 
since they act as general cell-wall lysis factors, also degrading 
the cell-wall of bacterial species different from the producer 
one [52]. This is an appreciated feature for a probiotic strain, 
since it can be useful in killing competitive pathogenic bacte-
ria, sharing the same ecological niche. Therefore their detec-
tion in the exoproteome of L. reuteri Lb2 BM can add con-
sistence to the hypothesized antibacterial potential of this 
species [2,3,4]. 
The second functional group consists of adhesion-involved 
proteins. It is a well established matter that these proteins 
play important roles in both pathogenic and probiotic 
strains for their ability to interact with gut epithelial mucosa 
[15,20,21]. Most adhesins are cytosolic enzymes having well-
proved moonlighting function when surface-bound or extra-
cellularly secreted.  
The evidences of the adhesive role of the surface-anchored 
Figure 2. 2DE map of extracellular proteins. Extracellular proteins 
maps in the acidic (4–7) pI range of L. reuteri Lb2 BM DSM 16143 
grown in a modified MRS medium and collected at the middle 
exponential phase. Twenty-one proteins were identified by 
nanoLC-chip MS/MS from fifty-nine detected spots. 
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Functional 
role  Spot  Score  Molecular Weight  Identified protein  NCBI nr ID 
N. of 
peptides 
Sequence 
coverage (%) 
Cell wall 
processing 
enzymes 
1 
1991  53593  mannosyl-glycoprotein 
endo-beta-N-
gi|148544583  41  87 
642  58147  N-acetylmuramoyl-L-
alanine amidase  gi|148544581  19  47 
2  367  24886  peptidoglycan-binding 
LysM  gi|148544536  7  34 
3  796  46733  NLP/P60 protein  gi|148544580  24  55 
4  874  21648  peptidoglycan-binding 
LysM  gi|148543651  18  75 
5  435  26683  unknown extracellular 
protein lr1267  gi|68160846  9  34 
6  117  21600  Apf1-like protein  gi|33112857  4  16 
Adhesion-
involved 
proteins 
7  1095  48010  phosphopyruvate 
hydratase (α-enolase)  gi|194468183  28  76 
8  1411  35971  glyceraldehyde 3-
phosphate dehydrogenase  gi|184153036  38  94 
9  1518  43405  elongation factor Tu  gi|148543883  38  73 
10  1096  31999  elongation factor Ts  gi|148543917  36  60 
11  1529  67171  molecular chaperone 
DnaK  gi|148543938  57  77 
12  687  42934  phosphoglycerate kinase  gi|184153037  30  74 
13  234  26105  phosphoglyceromutase  gi|148543385  8  48 
14  1432  48717  trigger factor  gi|148543884  43  60 
Other 
proteins 
15  3558  167804  dextransucrase  gi|184153923  109  73 
16  523  55934  sucrose phosphorylase  gi|148544754  18  47 
17 500  35941  mannitol dehydrogenase  gi|45268465  12  49 
18  857  36102  alcohol dehydrogenase  gi|148544709  26  55 
19  1130  91346  phosphoketolase  gi|148544892  32  39 
20  233  27144  hypothetical protein 
Lreu_0552  gi|148543787  7  25 
21  383  20771  ribosome recycling factor  gi|148543919  17  85 
elongation factor Tu has already been described in the previ-
ous paragraph. It is interesting to underline that EF-Tu (spot 
9) has been detected also in the extracellular proteome of 
Bifidobacterium animalis subsp. lactis where it acts as moon-
lighting protein with adhesion roles contributing to the pro-
biotic features of the strain [53]. EF-Ts (spot 10) has been 
classified as signal peptide-lacking exoprotein in both Staph-
ylococcus aureus [54] and Bacillus anthracis [55] and as sur-
face protein in Lactococcus lactis NZ9000 [56]. Also trigger 
factor (spot 14) was described to be exposed on the surface 
of Lactobacillus plantarum 299v [17]. It has been reported 
that surface adhesin P1 from Streptococcus mutans cannot 
efficiently work in the absence of both trigger factor and 
DnaK (spot 11) [57]. Furthermore, in L. reuteri NCIB 11951, 
a collagen I-binding protein that shares high sequence ho-
mology with E. coli trigger factor has been described [58]. 
The remaining identified proteins with adhesive function 
are moonlighting glycolytic enzymes. GAPDH (spot 8) is 
able to bind fibronectin, mucin and plasmin [59,60]; it has 
been found exposed on the surface of several Lactobacillus 
species (L. gallinarum, L. gasseri, L. johnsonii, L. amylo-
vorus, L. acidophilus and L. crispatus) where it exerts the ac-
tivity of fibronectin binding [61]. Phosphoglycerate kinase 
(PGK) (spot 12) has been referred to be extracellularly locat-
Table 2. The table lists the 21 identified proteins from extracellular 2DE maps of L. reuteri Lb2 BM 16143 divided in 3 different func-
tional groups: cell wall processing enzymes, adhesion involved proteins and other proteins. 
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ed in Lactobacillus rhamnosus GG [62] and surface-
associated in Lactococcus lactis IL1403 [63]. In eukaryotic 
cells it acts in the extracellular district as disulphide reduc-
tase and plasmin reductase [64]. Both activities are of inter-
est in a probiotic strain since this enzyme (supposing the 
same biological function in prokaryotes) could contribute to 
the antioxidant effect of L. reuteri Lb2 BM and to the deple-
tion from the extracellular environment of plasmin, a metab-
olite potentially able to activate proteolytic cascades [65].  
Among the third protein group, ribosome recycling factor 
(spot 21) was previously described in streptococci as an ex-
tracellular located protein [66], while sucrose phosphorylase 
(spot 16) and dextransucrase (spot 15) are correlated to the 
probiotic potential of LAB. In Lactobacillus acidophilus 
NCFM sucrose phosphorylase expression is induced by su-
crose. This enzyme is involved in the utilization and catabo-
lism of human undigested sugars like fructooligosaccharides 
(FOS), considered prebiotic compounds, thus stimulating 
the growth of the producing strain and promoting competi-
tion of beneficial bacteria in the human gut [67]. Very re-
cently [68] sucrose phosphorylase has been reported  as a 
clue enzyme in generating fructose units, building blocks  for 
the biosynthesis of the prebiotic functional sugars (i.e. FOS).  
Dextransucrase is an extracellular enzyme produced by sev-
eral genera of lactic acid bacteria such as Leuconostoc and 
Streptococcus [69]. It is a glycosyltransferase catalyzing the 
cleavage of sucrose into glucose and fructose and the follow-
ing polymerization of these glucosidic units into prebiotic 
molecules [70]. The finding of these proteins in the extracel-
lular environment of L. reuteri Lb2 BM DSM 16143 under-
lines the probiotic potential of this strain for successfully 
colonizing the gut ecological niche. 
The safety of the strain in the tested conditions is con-
firmed by the absence of potentially dangerous proteins such 
as extracellular serine protease and gelatinase recently de-
scribed in the extracellular space of a strain of Enterococcus 
faecalis, a lactic acid bacterium whose use in food industry is 
still controversial [28].  
3.5 Potential of L. reuteri Lb2 BM DSM 16143 surface-
associated proteins in plasminogen activation 
As reported in the previous paragraphs, some of the adhe-
sive proteins identified in both the cell-wall and the extracel-
lular space, also display the capability to bind plasminogen 
(Plg). Once localized to the bacterial surface, plasminogen 
can act as a cofactor in adhesion, or, following activation to 
plasmin (Plm), provide a source of potent proteolytic activity 
[71]. The activation to Plm may lead to damages to host tis-
sues, opening the way for invasion by potential pathogenic 
bacteria, present in the same ecological niche. The conver-
sion of Plg into Plm is a typical feature of several pathogenic 
bacteria, like staphylococci and streptococci, that possess 
staphylokinases and streptokinases which can act as specific 
activators [72]. 
The ability to convert Plg into Plm of L. reuteri Lb2 BM 
DSM 16143 was tested for both the whole bacterial cells and 
for surface-associated proteins recovered after cell treatment 
at pH 8. As shown in Figure 3 neither the whole cells nor the 
released proteins were able to induce Plm formation indicat-
ing the absence of the bacterial specific activators. The same 
assay was performed in presence of the mammalian tissue 
type Plg activator (tPA). As shown in Figure 3 in this condi-
tion both the whole bacterial cells and the surface-associated 
proteins were able, in presence of tPA, to produce Plm. This 
indicates that L. reuteri Lb2 BM DSM 16143 cells can immo-
bilize Plg on its surface and that this property seems to de-
pend on the surface-anchored moonlighting proteins.  
Even if the involvement of probiotic bacteria in the Plg/
Plm system is yet to be elucidated, the proved ability of Lac-
tobacillus reuteri to bind Plg on its surface could have a role in 
enhancing the colonization process at human epithelial sur-
faces, as already suggested by Candela and co-workers [44], 
or in localized dissolution of fibrin clots [22]. Furthermore 
the presence of Plg-binding proteins, either surface-bound 
or extracellularly released, could interfere in the interaction 
between Plg and gastrointestinal pathogens present in the 
same ecological niche, such as Helicobacter pylori and Sal-
monella sp., since probiotic bacteria could act as quenchers, as 
previously suggested by other authors [20]. 
 4. Concluding Remarks 
Integrating proteomic analyses with physiological studies 
proved to be a winning strategy to characterize a probiotic 
strain. 
The ability of L. reuteri Lb2 BM DSM 16143 to adhere to 
both Caco-2 cells and extracellular matrix proteins, especial-
ly collagen and laminin, was proven by in vitro adhesion 
assays. The involvement of weakly cell-surface anchored 
proteins in this phenomenon was demonstrated by the dras-
tic decrease in adhesion to ECM induced by their detach-
ment obtained with incubation at pH 8. SDS-PAGE analysis 
Figure 3. Evaluation of Plg-binding ability. Plasminogen activa-
tion assay of entire cells and surface-associated proteins (SAP) 
with and without mammalian tPA activator. Values were collected 
for 4 hours measuring absorbance at 405nm and are reported as 
mean ± SEM. 
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followed by MALDI-TOF TOF mass spectrometry revealed 
that the proteins involved in this process were mainly moon-
lighting proteins whose implication in adhesion has already 
been proved in both pathogenic and probiotic bacteria. The 
loss of adhesion ability induced by alkaline pH does not con-
stitute a problem in vivo considering that the pH of colon, 
the main district of probiotic action, is around 6-7. However, 
in vivo, the strain adhesion potential could further be im-
proved by the physiological activation of metabolic pathways 
leading to the expression of non-protein adhesive factors, 
such as the exopolysaccharides [73]. 
Extracellular proteomic profiles highlighted the presence 
of adhesive proteins also in this cell district. Among these are 
present glycolytic enzymes (GAPDH, PGM, PGK) as well as 
stress proteins (DnaK), trigger factor and protein synthesis 
enzymes (EF-Tu and Ts). The latter enzymes can also have 
an immune-modulating action. Since adhesion and immune 
system modulation are often related, the analysis of the ex-
tracellular proteomes proves to be a useful tool to obtain an 
overall picture of probiotic-host interaction, mainly in L. 
reuteri in which a strict link between adhesion and regulatory 
T-cell induction has been demonstrated [74]. Extracellular 
proteomics also revealed the presence of potential lytic fac-
tors, namely cell-wall hydrolases, useful in enhancing the 
antibacterial potential of the strain in the gut ecosystem and 
the total absence of virulence proteins. Furthermore proteins 
involved in the probiotic potential such as exopolysaccharide 
or fructooligosaccharide related enzyme have also been de-
tected.  
Some of the identified adhesins were reported to be able to 
link plasminogen; the strain was able to bind but not to acti-
vate plasminogen into plasmin without supplementation of 
exogenous activators like tPA. The expression of these Plg 
receptors is an useful feature because they can improve the 
adhesion ability of the tested strain and they can have a role 
in quenching Plg, subtracting it to pathogenic bacteria. 
Although in vivo tests at different physiological pHs and in 
different individual enterotypes [75] are necessary to prove 
the adhesive and persistence capabilities of this strain, the 
present  results enable us to assert that L. reuteri Lb2 BM can 
colonize the intestine, conferring to the host the benefits 
derived from its probiotic features. 
5. Supplementary material 
Supplementary data and information is available at: http://
www.jiomics.com/index.php/jio/rt/suppFiles/143/0 
Table S1 contains the sequences of peptides identified by 
nanoLC-chip MS/MS performed on the spots present in the 
extracellular 2DE maps. 
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